1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Analysis & Statistics in the United Kingdom, May 2020

Cancer Analysis & Statistics in the United Kingdom, May 2020

1-30 of about 200 reports

2020 UK Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • May 2020
  • 575 pages

2020 UK Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers High ...

  • Cancer
  • United Kingdom
  • Demand

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted EGFR-NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • United Kingdom
  • United States

Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted PD-L1 NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • United Kingdom
  • United States

Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical ...

  • Cancer
  • Lung Cancer
  • Pathology
  • France
  • United Kingdom

BRAF Mutated Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘BRAF Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted BRAF Mutated NSCLC epidemiology ...

  • Cancer
  • Lung Cancer
  • Pathology
  • France
  • United Kingdom

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Anaplastic lymphoma kinase-Non Small Cell Lung Cancer (ALK-NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted ALK NSCLCepidemiology ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Germany
  • United Kingdom

2020 UK Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities

  • $ 2500
  • April 2020
  • 527 pages

2020 UK Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities This new report ...

  • Cancer
  • Pathology
  • United Kingdom
  • Demand

2020 UK Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • April 2020
  • 527 pages

2020 UK Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report from  ...

  • Cancer
  • Pathology
  • United Kingdom
  • Forecast

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) - Epidemiology Forecast - 2030

  • $ 3750
  • April 2020
  • 72 pages

‘Blastic plasmacytoid dendritic cell neoplasm (BPDCN) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the BPDCN, historical and forecasted epidemiology in the United ...

  • Biopharmaceutical
  • Cancer
  • Cell Therapy
  • Medical Biotechnology
  • United Kingdom

Non-Small Cell Lung Cancer (NSCLC) KOL Interview – UK

  • $ 599
  • March 2020
  • 12 pages

This interview with a UK-based key opinion leader (KOL) provides insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for non-small cell lung cancer (NSCLC). Diagnostic ...

  • Cancer
  • Lung Cancer
  • Pathology
  • United Kingdom
  • Market Size

HER2+ Breast Cancer KOL Interview – UK

  • $ 599
  • March 2020
  • 17 pages

A UK-based key opinion leader (KOL) provides insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for HER2+ breast cancer. Diagnostic testing, biomarker disease segmentation, ...

  • Breast Cancer
  • Cancer
  • United Kingdom
  • Market Size

Bladder Cancer: Epidemiology Forecast to 2028

  • $ 3995
  • February 2020
  • 49 pages

Bladder Cancer: Epidemiology Forecast to 2028 Summary The financial burden of diagnosed bladder cancer is expected to grow between 2018 and 2028 in the seven major markets (The US, France, Germany, Italy, ...

  • Bladder Cancer
  • Cancer
  • Pathology
  • United Kingdom
  • Forecast

2020 UK Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 3500
  • February 2020
  • 575 pages

2020 UK Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities ...

  • Cancer
  • United Kingdom
  • Demand

UK Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 527 pages

UK Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 527 pages, 37 tables, and presents ...

  • Cancer
  • United Kingdom

UK Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 527 pages

UK Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report from  Lea ...

  • Cancer
  • United Kingdom
  • Forecast

Triple-Negative Breast Cancer KOL Interview – UK

  • $ 599
  • October 2019
  • 15 pages

A UK-based key opinion leader providers insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for triple- negative breast cancer. Diagnostic testing, biomarker disease ...

  • Cancer
  • Targeted Therapy
  • Therapy
  • United Kingdom
  • Market Size

Embolotherapy Market

  • $ 4900
  • September 2019
  • 336 pages

Embolotherapy Market Research Report: By Product (Embolic Agents, Support Devices), Procedure (Transcatheter Arterial Embolization, Transarterial Radioembolization/Selective Internal Radiation Therapy, ...

  • Cancer
  • Neurological Disorder
  • Pathology
  • United Kingdom
  • Demand

Rho Associated Protein Kinase 1 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019
  • 37 pages

Rho Associated Protein Kinase 1 - Pipeline Review, H2 2019 Summary According to the recently published report ’Rho Associated Protein Kinase 1 - Pipeline Review, H2 2019’; Rho Associated Protein Kinase ...

  • Cancer
  • Pharmaceutical
  • Specialty Hospital
  • United Kingdom
  • Astex Pharmaceuticals, Inc.

Ovarian Cancer: Epidemiology Forecast to 2028

  • $ 3995
  • July 2019
  • 46 pages

Ovarian Cancer: Epidemiology Forecast to 2028 Summary Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence and mortality worldwide. The disease is defined ...

  • Cancer
  • Ovarian Cancer
  • Japan
  • United Kingdom
  • Forecast

UK Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 4350
  • July 2019
  • 575 pages

UK Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities ...

  • Cancer
  • United Kingdom
  • Demand

UK Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

  • $ 2450
  • July 2019
  • 575 pages

UK Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023 HighlightsComprehensive 575-page ...

  • Cancer
  • United Kingdom
  • Market Shares

UK Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

  • $ 2500
  • May 2019
  • 527 pages

UK Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities This new report from VPGMarketResearch ...

  • Cancer
  • Pathology
  • United Kingdom
  • Demand

UK Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • May 2019
  • 527 pages

UK Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 527 pages, 37 tables, and presents ...

  • Cancer
  • Pathology
  • United Kingdom
  • Demand

UK Hospital Cancer Diagnostics Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • May 2019
  • 527 pages

UK Hospital Cancer Diagnostics Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report from  LeadingMarketResearch.com contains ...

  • Cancer
  • Pathology
  • United Kingdom
  • Demand

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019

  • $ 3500
  • April 2019
  • 40 pages

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019 Summary Rho ...

  • Cancer
  • Drug Development
  • Specialty Hospital
  • United Kingdom
  • Product Initiative

2019 UK Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • April 2019
  • 575 pages

2019 UK Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers HighlightsComprehensive 575-page ...

  • Cancer
  • United Kingdom
  • Market Shares

Datamonitor Healthcare Multiple Myeloma KOL Interview – Midwestern, US

  • $ 599
  • January 2019
  • 17 pages

Overview This interview covers the current treatment of multiple myeloma in the UK, and the main areas of unmet need. Looking forward, we discuss the likely uptake of recently approved regimens, as well ...

  • Cancer
  • United Kingdom
  • United States

Datamonitor Healthcare Multiple Myeloma KOL Interview – UK

  • $ 599
  • January 2019
  • 17 pages

Overview This interview covers the current treatment of multiple myeloma in the UK, and the main areas of unmet need. Looking forward, we discuss the likely uptake of recently approved regimens, as well ...

  • Cancer
  • United Kingdom

Datamonitor Healthcare HR+/HER2- Breast Cancer KOL Interview – UK

  • $ 599
  • January 2019
  • 14 pages

Overview A UK key opinion leader (KOL) provides insight into the current and future treatment dynamics of HR+/HER2- breast cancer, as well as critical unmet needs in the treatment space. Major marketed ...

  • Breast Cancer
  • Cancer
  • Pathology
  • United Kingdom

Owlstone Medical Ltd - Product Pipeline Analysis, 2018 Update

  • $ 750
  • December 2018
  • 37 pages

Summary Owlstone Medical Ltd (Owlstone Medical), formerly Tiger Dawn Ltd, is a diagnostic company.The company develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It ...

  • Biopsy
  • Cancer
  • United Kingdom
  • World
About 3700 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Hepatitis Statistics and Cancer Statistics in the UK

  • May 2020
  • 72 pages
  • Cancer
  • Hepatitis
  • Pathology
  • United Kingdom
  • Demographic

Therapy Market May 2020


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on